Product Name :
Anti-EGFL7, Human antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-EGFL7, Human antibody is designed for detecting human EGFL7 specifically. Based on ELISA and/or FCM, Anti-EGFL7, Human antibody reacts with human EGFL7 specifically. | Immunogen: Recombinant human EGFL7 | Host: Alpaca pacous | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Human EGFL7 | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% Glycerol | Storage: Store at –20 °C, (Avoid freeze / thaw cycles) | Background:Epidermal growth factor-like protein 7 (EGFL7), also known as VE-statin, MEGF7, Notch4-like protein or Zneu1, is a 29.6 kDa protein produced and secreted by endothelium. The protein is also expressed by some normal and malignant tissues. The main function of EGFL7 is to regulate angiogenesis and vasculogenesis. A high level of EFGL-7 can be found in tissues with active angiogenesis of a variety of disorders.
Description2 :
Anti-EGFL7, Human antibody is designed for detecting human EGFL7 specifically. Based on ELISA and/or FCM, Anti-EGFL7, Human antibody reacts with human EGFL7 specifically.
Immunogen:
Recombinant human EGFL7
Host :
Alpaca pacous
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Store at –20 °C, (Avoid freeze / thaw cycles)
Function:
ELISA: 1:4,000-1:10000Flow Cytometry：1:200-1:1000Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.HO-1 Protein, Human The actual dilution used must be determined empirically.D(+)-Galactosamine (hydrochloride)